Targeted new support will ensure new vaccines reach children across the country
Gavi CEO Dr Seth Berkley meets India Prime Minister Narendra Modi in New Delhi to discuss the immunisation partnership.
Credit: PMO, Government of India / 2016
New Delhi, 6 January 2016 – The Government of India and Gavi, the
Vaccine Alliance, have today announced a partnership that will help save the
lives of millions of Indian children through increased access to vaccines.
India is due to begin transitioning away from Gavi support from
2017 and is expected to begin fully self-financing all its vaccine programmes
by 2021. Under the partnership strategy, Gavi will provide up to US$ 500
million between 2016 and 2021 to support India’s immunisation programme, after
which India will completely transition out of Gavi support. The new partnership
will accelerate the introduction of modern, highly-efficacious vaccines in India,
protecting children against the leading causes of disease, including pneumonia
and severe diarrhoea, which combined claim the lives of more than 200,000 Indian
children under the age of five every year.
Support will also be made available for the measles-rubella combined
vaccine. This vaccine protects children against measles, a highly infectious
disease that kills almost 30,000 children in India every year, as well as congenital
rubella syndrome, which causes severe deformities and disabilities through the
spread of the virus from pregnant women to their babies. Gavi will also provide
future assistance for India to introduce the human papillomavirus vaccine,
should the Government approve its introduction. This vaccine protects women
against the leading cause of cervical cancer, a disease that kills 70,000 Indian
women every year.
Through this new partnership Gavi-supported vaccines administered
between 2016 and 2021 are expected to prevent several hundred thousand deaths. By
helping to establish these vaccines in India’s routine immunisation schedule and
by strengthening existing immunisation and health systems to extend coverage
and improve access, millions of children will benefit from the work being
undertaken now for generations to come.
The Government of India already has a priority of reaching every
child with vaccines, as is evidenced by its new Mission Indradhanush initiative,
which aims to reduce the number of children who get sick or die from
preventable diseases by ensuring that the number of infants receiving all
vaccines included within the Universal Immunisation Programme (UIP) exceeds 90%
within the next five years. Through the modernisation and strengthening of health
systems under this new partnership, Gavi support will also help towards this
goal and help engage with a broader community of stakeholders within India.
“One sixth of humanity resides in India, equivalent to 30 or 40
other poor countries. Therefore, preventing disease in India will have a truly
global impact,” said Prime Minister Narendra Modi. He went on to say that Indian
innovation can make a difference not only in India but across the globe.
“Together with WHO and UNICEF, Gavi’s support will help India to
turbo-charge its immunisation programmes, protecting more children more quickly,”
said Gavi CEO Dr Seth Berkley. “I applaud the Government of India, in
particular the leadership of the Prime Minister and the Health Minister, for
taking such a bold position on immunisation and for recognising the role it has
to play in protecting India’s children, and I am pleased with the part the
Vaccine Alliance is playing as a partner in this important work.”
Despite India’s recent successes in eliminating polio and
neonatal tetanus, the country is home to four million under-immunised children,
about a fifth of the total among Gavi-supported countries. Gavi and its
partners will provide targeted support to help India’s immunisation system
identify and reach children who are not receiving vaccines, including exploring
how India’s vast number of polio workers can support uptake of other routine
vaccines, such as the 5-in1 pentavalent vaccine and these new vaccines.
Currently 60% of all Gavi-procured vaccines are manufactured in
India. Through the partnership, Gavi and the Government of India will work more
closely together to help create a more sustainable global and domestic vaccine
manufacturing base within India. This will be crucial to ensuring sufficient vaccine
supplies are available for the 27 million children born in India every year,
and children living in all 72 other Gavi-supported countries.
Gavi, the Vaccine Alliance is funded by governments (Australia, Brazil, Canada, Denmark, France, Germany, India, Ireland, Italy, Japan, the Kingdom of Saudi Arabia, Luxembourg, the Netherlands, Norway, the People’s Republic of China, Republic of Korea, Russia, South Africa, Spain, the State of Qatar, the Sultanate of Oman, Sweden, United Kingdom, and United States), the European Commission, Alwaleed Philanthropies, the OPEC Fund for International Development (OFID), the Bill & Melinda Gates Foundation, His Highness Sheikh Mohamed bin Zayed Al Nahyan and Majid Al Futtaim, as well as private and corporate partners (Absolute Return for Kids, Anglo American plc., the A&A Foundation, The Children’s Investment Fund Foundation, Comic Relief, the ELMA Vaccines and Immunization Foundation, The International Federation of Pharmaceutical Wholesalers (IFPW), the Gulf Youth Alliance, JP Morgan, “la Caixa” Foundation, LDS Charities, Lions Clubs International Foundation, UPS and Vodafone.
Click to view the full donor list.